17 results on '"Pissot‐Soldermann, Carole"'
Search Results
2. N-aryl-piperidine-4-carboxamides as a novel class of potent inhibitors of MALT1 proteolytic activity
3. Optimization of the In Vivo Potency of Pyrazolopyrimidine MALT1 Protease Inhibitors by Reducing Metabolism and Increasing Potency in Whole Blood.
4. Discovery of Potent, Highly Selective, and In Vivo Efficacious, Allosteric MALT1 Inhibitors by Iterative Scaffold Morphing.
5. Stabilizing Inactive Conformations of MALT1 as an Effective Approach to Inhibit Its Protease Activity.
6. The T‐cell fingerprint of MALT1 paracaspase revealed by selective inhibition.
7. Discovery and SAR of potent, orally available 2,8-diaryl-quinoxalines as a new class of JAK2 inhibitors
8. Design of two new chemotypes for inhibiting the Janus kinase 2 by scaffold morphing
9. 2-Amino-aryl-7-aryl-benzoxazoles as potent, selective and orally available JAK2 inhibitors
10. An Asymmetric Synthesis of Hamigeran B via a Pd Asymmetric Allylic Alkylation for Enantiodiscrimination.
11. A Short and Concise Asymmetric Synthesis of Hamigeran B (I).
12. An Asymmetric Synthesis of Hamigeran B (VIII) via a Pd Asymmetric Allylic Alkylation for Enantiodiscrimination.
13. Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced Malignancies.
14. Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors.
15. Modulation of activation-loop phosphorylation by JAK inhibitors is binding mode dependent.
16. Potent and selective inhibition of polycythemia by the quinoxaline JAK2 inhibitor NVP-BSK805.
17. A short and concise asymmetric synthesis of hamigeran B.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.